NasdaqGS:TWSTBiotechs
Is Twist’s Expanded NGS Library Kit Portfolio and Higher 2026 Guidance Altering The Investment Case For Twist Bioscience (TWST)?
In early February 2026, Twist Bioscience Corporation launched the Twist TrueAmp Library Preparation Kit and the Twist PCR-Free WGS Library Preparation Kit, designed to improve next-generation sequencing workflows for low-input and challenging samples in clinical research.
By combining in-house engineered enzymes with PCR-free whole-genome sequencing options, Twist is aiming to improve data quality and scalability for researchers across applications like rare disease and cancer.
We will now...